City Therapeutics Prices Upsized IPO at $18.00 Per Share

Key Facts

City Therapeutics priced its upsized initial public offering at $18.00 per share. Investing.com reported that the company is proceeding with its public listing on the Nasdaq to raise capital, having benefited from sufficient investor demand to increase the size of the offering beyond previous expectations.

The official pricing follows a period of related IPO activity within the sector. By entering the public markets, the company aims to secure funding for its ongoing operations and growth, with the decision to upsize the deal reflecting investor interest in the new issuance.